BioCentury
ARTICLE | Emerging Company Profile

Arixa: Breaking resistance with oral beta lactamase inhibitors

Arixa's prodrug chemistry for oral beta-lactamase inhibitors

April 1, 2019 1:15 PM UTC

Arixa has made an IV antibiotic oral with prodrug chemistry.

Arixa Pharmaceuticals Inc. is modifying diazabicyclooctanes, a class of β-lactamase inhibitors that suffer from poor absorption across the GI tract, for use in combination with β-lactam antibiotics to treat Gram-negative infections. ...

BCIQ Company Profiles

Arixa Pharmaceuticals Inc.

BCIQ Target Profiles

Beta lactamase (LACTB)